BIOMAT Database Logo BIOMAT Database Logo

On the origin of the Aalpha chain heterogeneity of human fibrinogen. 1977

N Semeraro, and D Collen, and M Verstraete

UI MeSH Term Description Entries
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D001793 Blood Preservation The process by which blood or its components are kept viable outside of the organism from which they are derived (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism). Blood Preservations,Preservation, Blood,Preservations, Blood
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N Semeraro, and D Collen, and M Verstraete
Immunologic properties of Aalpha chain of human fibrinogen.
August 1974, European journal of biochemistry,
N Semeraro, and D Collen, and M Verstraete
Human fibrinogen heterogeneities: determination of the major Aalpha chain derivatives in blood.
August 1983, Thrombosis research,
N Semeraro, and D Collen, and M Verstraete
Novel fibrinogen Aalpha chain mutation associated with afibrinogenaemia.
October 2007, Pathology,
N Semeraro, and D Collen, and M Verstraete
Preparation and evaluation of an antiserum to the carboxymethylated Aalpha chain of human fibrinogen.
June 1978, Thrombosis and haemostasis,
N Semeraro, and D Collen, and M Verstraete
Metabolic studies on human fibrinogen gamma/gamma' chain heterogeneity.
September 1980, Blood,
N Semeraro, and D Collen, and M Verstraete
Low expression of truncated Aalpha chain variant in circulating fibrinogen.
September 2002, Thrombosis and haemostasis,
N Semeraro, and D Collen, and M Verstraete
The non-plasmin, proteolytic origin of human fibrinogen heterogeneity.
October 1971, Biochimica et biophysica acta,
N Semeraro, and D Collen, and M Verstraete
A frameshift mutation in the human fibrinogen Aalpha-chain gene (Aalpha(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo.
December 2001, Thrombosis and haemostasis,
N Semeraro, and D Collen, and M Verstraete
Three German fibrinogen Aalpha-chain amyloidosis patients with the p.Glu526Val mutation.
July 2008, Virchows Archiv : an international journal of pathology,
N Semeraro, and D Collen, and M Verstraete
Mechanism of action of thrombin on fibrinogen. Reaction of the N-terminal CNBr fragment from the Aalpha chain of human fibrinogen with bovine thrombin.
October 1974, Archives of biochemistry and biophysics,
Copied contents to your clipboard!